Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
The proposed transactions may contain terms that could limit superior competing offers.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
NEW YORK, July 27, 2026 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Forte Biosciences, Inc. (NASDAQ: FBRX)’s sale to argenx for $77.00 per share in cash. If you are a Forte shareholder, click here to learn more about your rights and options.
Arcosa, Inc. (NYSE: ACA)’s sale to CRH for $150.00 per share. If you are an Arcosa shareholder, click here to learn more about your rights and options.
Bio Green Med Solution, Inc. (NASDAQ: BGMS)’s merger with Future NRG Sdn. Bhd. If you are a Bio Green shareholder, click here to learn more about your legal rights and options.
On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/are-fbrx-aca-bgms-obtaining-fair-deals-for-their-shareholders-302835741.html
SOURCE Halper Sadeh LLP
